N+ Burger's concept of a “Farm to Burger" store in Hong Kong involves running pastures in Australia to ensure the quality of its beef.
Located at Swatow Street in Wan Chai, N+ Burger’s dishes are made from Hunter Beef Angus Cattle from their ranch.
Some of its pastures, including Glenrock Station, Brindley Park Clear Hils, and Oak Park, primarily breed pure Black Angus cattle with good genes, market recognition, and qualification.
The beef garnered gold and silver medals for Sydney’s ‘Royal Cruises’ in 2021 and last year, respectively.
N+ Burger uses 100 percent natural Angus meat, sourdough bread, fresh premium ingredients to make a range of burgers.
N+ Burger aims to offer a new lunch option for professionals and nearby communities, as well as a great gathering area for burger fans and foodies.


Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Dollar Struggles as Policy Uncertainty Weighs on Markets Despite Official Support
Asian Stocks Waver as Trump Signals Fed Pick, Shutdown Deal and Tech Earnings Stir Markets
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Gold and Silver Prices Plunge as Trump Taps Kevin Warsh for Fed Chair
Copper Prices Hit Record Highs as Metals Rally Gains Momentum on Geopolitical Tensions
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Canada’s local food system faces major roadblocks without urgent policy changes
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
Wall Street Slides as Warsh Fed Nomination, Hot Inflation, and Precious Metals Rout Shake Markets
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster
What’s the difference between baking powder and baking soda? It’s subtle, but significant
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 



